Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual Meeting in San Diego, CA.
Future Therapies for AML including Mitostory, CPX-351, IDH-1, & IDH-2
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual Meeting in San Diego, CA.